HSP90AA1 and neoplasm: Mechanistically, tumor-isolated HSP90-peptide complexes interact with scavenger receptor expressed by endothelial cells (SREC-I) on APCs, leading to their cross-presentation via MHC class I or more standard MHC class II antigen presentation pathway (2, 74).